Skip to main content

Jeffrey Rathmell, Ph.D.

  • Co-Leader, Host-Tumor Interactions Research Program
  • Cornelius Vanderbilt Professor of Immunobiology
  • Professor of Pathology, Microbiology and Immunology
  • Director, Vanderbilt Center for Immunobiology

Phone

615-322-3234

Email

jeff.rathmell@vanderbilt.edu
Vanderbilt-Ingram Cancer Center
648-B Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Jeffrey Rathmell, Ph.D.

  • Co-Leader, Host-Tumor Interactions Research Program
  • Cornelius Vanderbilt Professor of Immunobiology
  • Professor of Pathology, Microbiology and Immunology
  • Director, Vanderbilt Center for Immunobiology

615-322-3234

jeff.rathmell@vanderbilt.edu

Vanderbilt-Ingram Cancer Center
648-B Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Profile

Education

  • Ph.D., Immunology, Stanford University, Stanford, California (1997)
  • B.S., Biology, University of Northern Iowa, Cedar Falls, Iowa (1991)

Research Emphasis

Immunometabolism in inflammatory disease, cancer, and anti-tumor immunity

Research Description

There has been a growing appreciation that metabolism is intimately linked to nearly all aspects of cell function and fate. The field of immunometabolism aims to understand how metabolic pathways are regulated in immune cells, how specific metabolic programs alter immune function, and how immunity in turn may influence metabolism. The Rathmell lab focuses on how metabolic pathways influence the function and fate of lymphocytes in inflammatory diseases, anti-tumor immunity, and in leukemia. Our work is highly interdisciplinary and involves the fields of immunology, cancer biology, and cell metabolism. Ultimately the goals of these projects are to exploit the specific metabolic programs of each cell type or activation state to selectively impact effector lymphocytes in inflammatory diseases and leukemic cells in cancer.

Publications

Have any questions? Contact Us 1-877-936-8422 for more information